Edward Nesbitt Wilson, PhD

Affiliations: 
2011-2016 Pharmacology and Therapeutics McGill University, Montreal, QC, Canada 
 2016- Neurology Stanford University, Palo Alto, CA 
Area:
Alzheimer's disease,
Google:
"Edward Wilson"
Mean distance: 33.28
 
Cross-listing: Alzheimer's Tree - Cell Biology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Winer JR, Vossler H, Young CB, et al. (2024) F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease. Brain Communications. 7: fcae458
Trelle AN, Young CB, Vossler H, et al. (2024) Plasma Aβ/Aβ is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sheng J, Trelle AN, Romero A, et al. (2024) Top-down attention and Alzheimer's pathology impact cortical selectivity during learning, influencing episodic memory in older adults. Biorxiv : the Preprint Server For Biology
Wilson E, Umans J, Swarovski M, et al. (2024) Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction. Research Square
Minhas PS, Jones JR, Latif-Hernandez A, et al. (2024) Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies. Science (New York, N.Y.). 385: eabm6131
Minhas PS, Jones JR, Latif-Hernandez A, et al. (2024) Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies. Biorxiv : the Preprint Server For Biology
Abdelnour C, Young CB, Shahid-Besanti M, et al. (2024) Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease. Annals of Neurology
Wilson EN, Wang C, Swarovski MS, et al. (2024) TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models. Nature Neuroscience
Plastini MJ, Abdelnour C, Young CB, et al. (2024) Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra. Annals of Clinical and Translational Neurology
Cruchaga C, Ali M, Shen Y, et al. (2024) Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease. Research Square
See more...